Jane Street’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $131M | Buy |
2,163,700
+181,800
| +9% | +$10.6M | 0.02% | 529 |
|
|
2025
Q4 | $107M | Buy |
1,981,900
+203,800
| +11% | +$9.8M | 0.02% | 554 |
|
|
2025
Q3 | $80.2M | Buy |
1,778,100
+232,900
| +15% | +$10.9M | 0.01% | 691 |
|
|
2025
Q2 | $71.5M | Sell |
1,545,200
-2,951,800
| -66% | -$145M | 0.01% | 591 |
|
|
2025
Q1 | $274M | Buy |
4,497,000
+104,900
| +2% | +$6.11M | 0.07% | 165 |
|
|
2024
Q4 | $248M | Sell |
4,392,100
-218,900
| -5% | -$12.2M | 0.05% | 207 |
|
|
2024
Q3 | $239M | Buy |
4,611,000
+8,500
| +0.2% | +$399K | 0.05% | 191 |
|
|
2024
Q2 | $191M | Buy |
4,602,500
+3,710,300
| +416% | +$166M | 0.04% | 219 |
|
|
2024
Q1 | $48.4M | Buy |
892,200
+406,500
| +84% | +$20.7M | 0.01% | 645 |
|
|
2023
Q4 | $24.9M | Sell |
485,700
-9,059,500
| -95% | -$476M | 0.01% | 1091 |
|
|
2023
Q3 | $554M | Buy |
9,545,200
+9,375,500
| +5,525% | +$574M | 0.18% | 54 |
|
|
2023
Q2 | $10.9M | Buy |
169,700
+7,200
| +4% | +$483K | ﹤0.01% | 1818 |
|
|
2023
Q1 | $11.3M | Sell |
162,500
-454,800
| -74% | -$32.1M | ﹤0.01% | 1525 |
|
|
2022
Q4 | $44.4M | Sell |
617,300
-58,300
| -9% | -$4.4M | 0.02% | 582 |
|
|
2022
Q3 | $48M | Sell |
675,600
-734,100
| -52% | -$53.3M | 0.02% | 540 |
|
|
2022
Q2 | $109M | Buy |
1,409,700
+456,900
| +48% | +$34.8M | 0.05% | 289 |
|
|
2022
Q1 | $69.6M | Sell |
952,800
-76,400
| -7% | -$5.13M | 0.02% | 531 |
|
|
2021
Q4 | $64.2M | Buy |
1,029,200
+328,700
| +47% | +$19.3M | 0.02% | 544 |
|
|
2021
Q3 | $41.4M | Buy |
700,500
+318,600
| +83% | +$21M | 0.01% | 688 |
|
|
2021
Q2 | $25.5M | Buy |
381,900
+18,400
| +5% | +$1.2M | 0.01% | 904 |
|
|
2021
Q1 | $22.9M | Sell |
363,500
-179,400
| -33% | -$11.2M | 0.01% | 873 |
|
|
2020
Q4 | $33.7M | Sell |
542,900
-94,500
| -15% | -$5.81M | 0.02% | 597 |
|
|
2020
Q3 | $38.4M | Sell |
637,400
-22,100
| -3% | -$1.33M | 0.02% | 488 |
|
|
2020
Q2 | $38.8M | Buy |
659,500
+306,800
| +87% | +$18.4M | 0.03% | 445 |
|
|
2020
Q1 | $19.7M | Buy |
352,700
+201,200
| +133% | +$12.3M | 0.02% | 470 |
|
|
2019
Q4 | $9.72M | Sell |
151,500
-512,800
| -77% | -$29.4M | 0.01% | 657 |
|
|
2019
Q3 | $33.7M | Buy |
664,300
+469,600
| +241% | +$22.1M | 0.06% | 236 |
|
|
2019
Q2 | $8.83M | Sell |
194,700
-866,800
| -82% | -$40.4M | 0.02% | 698 |
|
|
2019
Q1 | $50.6M | Buy |
1,061,500
+1,018,400
| +2,363% | +$50.7M | 0.08% | 170 |
|
|
2018
Q4 | $2.24M | Sell |
43,100
-10,200
| -19% | -$548K | ﹤0.01% | 1601 |
|
|
2018
Q3 | $3.31M | Sell |
53,300
-192,300
| -78% | -$11.4M | 0.01% | 1392 |
|
|
2018
Q2 | $13.6M | Buy |
245,600
+184,800
| +304% | +$9.98M | 0.03% | 460 |
|
|
2018
Q1 | $3.85M | Buy |
60,800
+9,600
| +19% | +$618K | 0.01% | 1190 |
|
|
2017
Q4 | $3.14M | Sell |
51,200
-300
| -0.6% | -$18.8K | 0.01% | 1195 |
|
|
2017
Q3 | $3.28M | Buy |
51,500
+26,200
| +104% | +$1.53M | 0.01% | 1175 |
|
|
2017
Q2 | $1.41M | Sell |
25,300
-2,400
| -9% | -$131K | ﹤0.01% | 1840 |
|
|
2017
Q1 | $1.51M | Sell |
27,700
-19,200
| -41% | -$1.05M | 0.01% | 1634 |
|
|
2016
Q4 | $2.74M | Buy |
46,900
+700
| +2% | +$38.3K | 0.01% | 1041 |
|
|
2016
Q3 | $2.49M | Buy |
46,200
+26,800
| +138% | +$1.72M | 0.01% | 1022 |
|
|
2016
Q2 | $1.43M | Sell |
19,400
-37,200
| -66% | -$2.63M | 0.01% | 1603 |
|
|
2016
Q1 | $3.62M | Buy |
56,600
+47,800
| +543% | +$3.01M | 0.02% | 740 |
|
|
2015
Q4 | $605K | Buy |
+8,800
| New | +$582K | ﹤0.01% | 2278 |
|
|
2015
Q2 | – | Sell |
-9,600
| Closed | -$619K | – | 3624 |
|
|
2015
Q1 | $619K | Buy |
+9,600
| New | +$601K | ﹤0.01% | 1835 |
|
Other funds holding BMY
VCM
VPM
Jane Street's BMY Position: Q1 2026 in Review
Jane Street increased its Bristol-Myers Squibb (BMY) stake by 1,287% in Q1 2026, buying an estimated $123M and bringing the position to 2,265,508 shares worth $137M. The position accounts for 0.02% of the portfolio, ranked #518.
Jane Street first reported a position in BMY in Q2 2013 and has held it in 50 quarters since. The position peaked at $234M in Q4 2023. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Jane Street held 2,265,508 shares of Bristol-Myers Squibb worth $137M as of Q1 2026.
- Jane Street bought 2,102,131 Bristol-Myers Squibb shares in Q1 2026, an estimated $123M.
- Bristol-Myers Squibb made up 0.02% of Jane Street's portfolio in Q1 2026, its #518 holding.
- Jane Street first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 50 quarters since.
- Jane Street's Bristol-Myers Squibb position peaked at $234M in Q4 2023.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.